Home > Applications > Infectious Disease

Infectious Disease

Screen the Unseen

Maximise your potential to uncover and indentify infectious pathogens

Infectious disease genetic testing involves analysing the genetic material of pathogens, such as bacteria, viruses, or parasites, to identify specific strains or variations associated with infectious or pathogenic diseases. This testing helps in diagnosing infections, determining the source and transmission routes, monitoring the spread of outbreaks, and guiding treatment decisions, including the selection of appropriate antimicrobial agents. By characterising the genetic makeup of infectious agents, clinicians can better understand their virulence, drug resistance patterns, and potential for vaccine development. This information aids in implementing targeted control and prevention measures, ultimately contributing to more effective disease management and public health interventions.

Decode Science can assist infectious disease groups to improve their outcomes by working together on their entire workflow. From automation and sequencers, customised small and large targeted sequencing panels and library prep kits and more. At Decode Science, we pride ourselves on the level of flexibility, customisation, and collaboration we bring when working together to come up with a solution that improves outcomes for you and patients.

High-efficiency guide RNAs for knockouts and knock-ins.
CRISPR experts agree that using synthetic single guide RNAs (sgRNAs) for genome engineering generate more efficient and consistent editing results than any other type of guide RNAs.
Synthego sgRNAs are highly pure guides that deliver indel frequencies of up to 99%, making it easy to efficiently conduct knockout or knock-ins in virtually any cell type. Their sgRNAs can be ordered with site-specific chemical modifications that provide greater stability and decreased activation of the cellular innate immune response.
Twist Bioscience

Twist Bioscience

Twist Bioscience, headquartered in South San Francisco, is a prominent biotechnology company specializing in the manufacture of synthetic DNA and DNA products for diverse industries. Established in 2013 by Emily Leproust, Bill Banyai, and Bill Peck, Twist Bioscience has quickly emerged as a leader in the field.

In March 2021, the company was represented by Emily Leproust at a tabletop exercise during the Munich Security Conference. The simulation focused on an outbreak of weaponized monkeypox, showcasing Twist Bioscience's involvement in addressing critical global challenges. In May 2021, Twist Bioscience collaborated with the Genome Project-Write to launch a groundbreaking Computer-Aided Design (CAD) platform for whole genome design. This innovative platform automates workflows, facilitating collaborative efforts essential for scaling up genome design—from designing plasmids to megabases across entire genomes. This initiative marks a significant advancement in genomic research and underscores Twist Bioscience's commitment to driving progress through technology and collaboration.




MGI, also known as MGI Tech, is a prominent Chinese biotechnology company specializing in a comprehensive array of products and technologies catering to the genetic sequencing, genotyping, gene expression, and proteomics markets. Headquartered in Shenzhen, China, MGI has established itself as a leading provider of innovative solutions to meet the evolving needs of the biotechnology and life sciences industries. With its diverse product line and cutting-edge technologies, MGI is dedicated to advancing research and applications in genomics and proteomics fields, contributing to scientific breakthroughs and advancements worldwide.



seqWell is on a mission to redefine NGS library preparation, unlocking the full potential of today's DNA sequencing instruments. At the heart of our innovation lies the plexWell™ platform, a groundbreaking library preparation technology that revolutionizes multiplexing by enabling simple and scalable processing of hundreds to thousands of samples without the need for time- and cost-consuming normalization steps.

The plexWell platform boasts a wide-ranging impact across various applications, including synthetic biology, targeted sequencing, single-cell analysis, and both low- and high-depth sequencing of human, plant, animal, and microbial genomes. By eliminating the complexities associated with traditional library preparation methods, plexWell empowers researchers to accelerate their sequencing workflows while maximizing throughput and efficiency.




BiOptic, Inc. is a pioneering biotechnology instrument company dedicated to the development, manufacturing, and marketing of fully-integrated systems and tests for Fluorescence Immunoassay analysis across various sectors, including research, clinical, and industrial markets. The cutting-edge systems empower rapid and sophisticated Antibody-Antigen interaction testing, automating complex manual laboratory procedures for enhanced efficiency and accuracy.

The user-friendly systems seamlessly integrate multiple intricate and time-consuming steps, such as sample preparation and detection, streamlining the analysis of complex biological samples. Central to the technology are the proprietary pen-size gel-cartridges, which facilitate the efficient processing of samples within the systems.


Let’s Find You an Application That Helps Your Research

Get a call from your local Decode Science representative to help you find the best fit genomics products for you.